Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Back to The Tape

GlobeNewsWire

25 Jun 2026, 00:22 UTC · 3h ago

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss – Hagens Berman

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

ShareX LinkedIn

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss – Hagens Berman

What the story claims

3 claims · each scored for market impact

What matters in this story

1
A patient treated with Erasca's ERAS-0015 drug candidate died one month after receiving the treatment. — Patient death is a critical safety signal that can lead to clinical hold or complete failure of a drug candidate.
-0.90
2
Revolution Medicines (RevMed) has accused Erasca of patent infringement and misappropriation of trade secrets regarding ERAS-0015. — Intellectual property disputes threaten the company's ability to commercialize its lead asset and its competitive 'moat'.
-0.70
3
Erasca is facing a securities class action lawsuit alleging it misled investors regarding ERAS-0015's safety and intellectual property. — Legal actions introduce additional financial liabilities and management distraction, though they follow the primary negative catalyst.
-0.40

Which stocks this story touches

6 related stories

GlobeNewsWire
3h ago
GRAIL, Inc. (GRAL) Faces Securities Class Action Amid NHS-Galleri Trial Failure, $2.2B Market Cap Wipeout -- HBSS
- class action
- clinical trial
- litigation
Read

Erasca, Inc. (ERAS) Faces… — EMBC -1.00 | NewsImpactScreener

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss – Hagens Berman

What matters in this story

GRAIL, Inc. (GRAL) Faces Securities Class Action Amid NHS-Galleri Trial Failure, $2.2B Market Cap Wipeout -- HBSS

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss – Hagens Berman

What matters in this story

GRAIL, Inc. (GRAL) Faces Securities Class Action Amid NHS-Galleri Trial Failure, $2.2B Market Cap Wipeout -- HBSS

How each ticker is affected

Connected tickers

Track these names every morning.

Impact by category

Biggest drivers

Most positively impacted

Most negatively impacted

NASDAQ: ENSG Investigation: Kessler Topaz Meltzer & Check, LLP Encourages The Ensign Group, Inc. (NASDAQ: ENSG) Investors to Contact the Firm

Via Transportation, Inc. Securities Class Action Result of Undisclosed Growth Obstacles and approximately 70% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Activision Blizzard, Inc. Notice of June 30, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Via Transportation, Inc. (VIA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Hagens Berman Alerts PicS N.V. (PICS) Investors to Securities Class Action Related to IPO Omissions Regarding Credit Procedures and Quality

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss – Hagens Berman

What matters in this story

Next reads from the same story arc

GRAIL, Inc. (GRAL) Faces Securities Class Action Amid NHS-Galleri Trial Failure, $2.2B Market Cap Wipeout -- HBSS

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss – Hagens Berman

What matters in this story

Next reads from the same story arc

GRAIL, Inc. (GRAL) Faces Securities Class Action Amid NHS-Galleri Trial Failure, $2.2B Market Cap Wipeout -- HBSS

How each ticker is affected

Connected tickers

Track these names every morning.

Impact by category

Biggest drivers

Most positively impacted

Most negatively impacted

NASDAQ: ENSG Investigation: Kessler Topaz Meltzer & Check, LLP Encourages The Ensign Group, Inc. (NASDAQ: ENSG) Investors to Contact the Firm

Via Transportation, Inc. Securities Class Action Result of Undisclosed Growth Obstacles and approximately 70% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Activision Blizzard, Inc. Notice of June 30, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Via Transportation, Inc. (VIA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Hagens Berman Alerts PicS N.V. (PICS) Investors to Securities Class Action Related to IPO Omissions Regarding Credit Procedures and Quality